Looking at the universe of stocks we cover at Dividend Channel, in trading on Monday, shares of Stifel Financial Corporation (Symbol: SF) were yielding above the 2% mark based on its quarterly ...
Stifel Nicolaus analyst Annabel Samimy maintained a Buy rating on Altimmune (ALT – Research Report) today and set a price target of $18.00. The ...
Neumora Therapeutics (NASDAQ:NMRA) fell ~11% in the premarket on Friday as Stifel downgraded the biotech after efficacy concerns prompted J&J (NYSE:JNJ) to discontinue a late-stage program called ...
Stifel Financial Corporation (Symbol: SF) presently has an excellent rank, in the top 25% of the coverage universe, which suggests it is among the top most "interesting" ideas that merit further ...
Fintel reports that on March 4, 2025, Stifel downgraded their outlook for Global Partners LP - Limited Partnership (NYSE:GLP) ...
Investing.com -- Stifel downgraded Vertex (NASDAQ:VRTX), Inc to “Hold” from “Buy” and lowered its price target to $31 from $35, over the company’s investment strategy and valuation.
Stifel Financial Corp., headquartered in St ... are traded on the New York Stock Exchange under the symbols SF, SF-PB, SF-PC, SF-PD, and SFB respectively. Investors and stakeholders can access ...
Scotts Miracle-Gro (NYSE:SMG) on Tuesday rose as much as 5.8% after analysts at financial-services firm Stifel upgraded the ...
Company Information Stifel Financial Corp. (NYSE: SF) is a financial services holding company headquartered in St. Louis, Missouri, that conducts its banking, securities, and financial services ...
Stifel Financial Corp. provides securities brokerage, investment banking, trading, investment advisory and related financial services. It operates through the following segments: Global Wealth ...